


Wednesday, October 28, 2026
Research created at 1:55 PM ET, October 28, 2026 · Full analysis
1. EXECUTIVE SUMMARY
• THE DATE AND ANALYST MATTER. An October 27 GMT EIGHT account of Morgan Stanley research identifies MongoDB (MDB) and Palantir (PLTR) as beneficiaries of open-weight AI adoption. That thematic connection should be distinguished from the separate ratings and price targets issued around each company. [3]
• MONGODB’S CASE CENTERS ON DATABASE GROWTH. September 29 Investor Day coverage put AI-native Atlas revenue growth at 165% year over year, but its contribution at roughly 3%–5% of total revenue—a strong growth signal whose small base still matters. [5]
• PALANTIR’S GOLDMAN SACHS CASE CENTERS ON SOVEREIGN AI AND DEPLOYMENT ECONOMICS. Goldman upgraded PLTR from Neutral to Buy on October 8, with a $230 12-month target and approximately 18% upside against the then-referenced $194.12, not today’s price. [4]
• TARGETS DESCRIBE DIFFERENT JUDGMENTS, NOT A UNIFIED BASKET. Morgan Stanley’s post-Investor Day MDB target was $430; Cantor Fitzgerald reiterated $540 on October 5. PLTR’s October 28 consensus mean was approximately $208.97, with an $80–$265 range. [5][6][7]
• VALUATION FACES AN IMMEDIATE MACRO TEST. At 1:55 PM ET, QQQ was 722.68, up 0.20%, while IEF and TLT were each down 0.21%. The 10-year Treasury yield closed October 27 at 4.99%, making the discount rate an important counterweight to software’s AI growth narrative. [1][2]
• THE NEXT COMPANY-SPECIFIC CHECKPOINT IS NOVEMBER 2. Palantir’s scheduled earnings follow today’s Federal Reserve decision and after-close Alphabet and Microsoft results, which could reset expectations for AI demand and spending discipline. [7][23][38]
2. WHAT IS HAPPENING
As of Wednesday, October 28, at 1:55 PM ET, MDB and PLTR are connected by a reported Morgan Stanley thematic argument, but their individual investment cases have different origins. GMT EIGHT’s October 27 account names both among beneficiaries of rising open-weight model adoption, arguing that enterprise context and pricing power can remain valuable as intelligence becomes cheaper. The relevant development is yesterday’s thematic coverage—not a new rating action today. [3]
The chronology separates the claims investors should attach to each name:
• SEPTEMBER 29, 2026: Firm and company Morgan Stanley / MongoDB · Published position Overweight; $430 target following Investor Day · How to read it A company-specific growth outlook and valuation judgment. [5]
• OCTOBER 5, 2026: Firm and company Cantor Fitzgerald / MongoDB · Published position Overweight reiterated; $540 target · How to read it A separate firm’s assessment of Atlas trends and financial prospects. [6]
• OCTOBER 8, 2026: Firm and company Goldman Sachs / Palantir · Published position Neutral to Buy; $230 12-month target · How to read it A sovereign-AI and deployment-scaling thesis. [4]
• OCTOBER 27, 2026: Firm and company Morgan Stanley / MDB and PLTR · Published position Named in coverage of open-weight AI beneficiaries · How to read it A shared thematic classification, distinct from the rating actions above. [3]
A BENEFICIARY LIST, A RATING CHANGE AND A CONSENSUS TARGET ARE DIFFERENT RESEARCH PRODUCTS. Combining them can create the appearance of one coordinated recommendation even though the dates, firms and underlying arguments differ. The October 27 account supports discussing MDB and PLTR together on open-weight adoption; the earlier company notes explain why each might benefit differently. [3][4][5][6]
3. WHY IT IS HAPPENING
Morgan Stanley’s reported mechanism is that open-weight models lower the cost of producing “effective intelligence,” while established software vendors retain value through enterprise context and compliance assets. The investment implication is a potential shift in value from the model itself toward the software that makes its output useful inside an organization. That is an economic thesis, not an automatic earnings outcome. [3]
For MongoDB, September 29 Investor Day coverage described a three-year total-revenue growth objective above 20% and Atlas growth in the mid-20% range. Approximately 2,200 AI-native customers contributed an estimated 2.5–4 percentage points to Atlas growth. Those figures suggest AI is becoming a measurable demand source, although the 3%–5% total-revenue share limits how directly investors should extrapolate the 165% AI-native growth rate to the whole company. [5]
The broader adoption measure is also important: roughly 40% of Atlas annual recurring revenue had at least one AI use case, versus 30% previously. That is a different measure from revenue generated by AI-native customers. Together, the figures suggest both deeper use by existing customers and growth from newer AI businesses; treating them as interchangeable would overstate the precision of AI revenue attribution. [5]
Goldman’s October 8 Palantir thesis instead emphasized sovereign AI, bespoke vertical software and the forward-deployed-engineer model. Its argument was that AI automation could help scale that human-and-technology deployment approach, supporting a step-change in the addressable market. The key economic question is therefore whether broader demand can translate into more repeatable delivery, rather than simply more implementation work. [4]
Today’s backdrop raises the hurdle for both stories. Alphabet enters its after-close results with expected revenue growth of 25%, potentially its fastest since 2021, but shares had fallen in five of the previous six sessions through Tuesday and were down approximately 7% in October. That combination suggests investors want evidence of returns on AI spending, not spending growth alone. [10]
4. WHO IS AFFECTED
MongoDB (MDB)
MongoDB’s operating evidence is broader than the AI-native cohort. Cantor’s October 5 commentary cited subscription ARR of $2.89 billion, up approximately 25% year over year, alongside a $1 billion buyback. The implication is that the company’s AI narrative should be evaluated against overall recurring-revenue expansion and capital allocation, rather than only its fastest-growing customer segment. [6]
October consensus data covered 41 analysts, with a mean target near $456.76 and a $315–$560 range. Morgan Stanley’s $430 and Cantor’s $540 sit at different points within that range, illustrating materially different valuation judgments despite both firms’ Overweight ratings. [5][6][8]
Palantir Technologies (PLTR)
Nexqual’s October 28 snapshot put PLTR near $194.50, against a consensus mean target of approximately $208.97 and a Hold consensus rating. Goldman’s $230 target sits above that mean, while the full $80–$265 range indicates substantial disagreement over valuation. Goldman’s upgrade should therefore be read as a specific bullish view, not as the consensus position. [4][7]
SOFTWARE EQUITIES AND AI FINANCING
At 1:55 PM ET, the Nasdaq-100’s QQQ ETF was 722.68, within its 720.30–724.73 intraday range and below its 724.12 opening price, despite gaining 0.20% from the previous close. This is a modestly positive technology backdrop, not evidence by itself of a company-specific reaction to the Morgan Stanley coverage. [1]
Meanwhile, IEF was 90.91 and TLT 81.46, both down 0.21%. Falling Treasury ETF prices indicate upward yield pressure, which can restrain the present value investors assign to distant software profits. Separately, scrutiny of debt-funded AI infrastructure has intensified around CoreWeave; that raises the importance of distinguishing software monetization from the financing risks of the infrastructure supporting it. [1][36]
5. THE NUMBERS
• MDB AI-NATIVE ATLAS REVENUE, SEPTEMBER 29 COVERAGE: Latest Approximately 3%–5% of total revenue · Change +165% year over year · What is driving it Rapid expansion from a relatively small base. [5]
• ATLAS ARR WITH AT LEAST ONE AI USE CASE: Latest Approximately 40% · Change From 30% · What is driving it Broader AI adoption within the customer base. [5]
• MDB SUBSCRIPTION ARR, OCTOBER 5 COMMENTARY: Latest $2.89 billion · Change Approximately +25% year over year · What is driving it Recurring-revenue expansion cited by Cantor. [6]
• MDB MEDIUM-TERM GROWTH OBJECTIVES: Latest Total revenue >20%; Atlas mid-20% range · Change Raised at Investor Day · What is driving it Management’s three-year growth outlook. [5]
• MDB ANALYST TARGETS: Latest Morgan Stanley $430; Cantor $540 · Change / · What is driving it Separate post-Investor Day assessments. [5][6]
• PLTR GOLDMAN TARGET, OCTOBER 8: Latest $230 over 12 months · Change Neutral to Buy · What is driving it Sovereign AI and deployment scaling. [4]
• PLTR OCTOBER 28 SNAPSHOT: Latest Approximately $194.50; mean target $208.97 · Change / · What is driving it Consensus target range of $80–$265. [7]
• NASDAQ-100, QQQ ETF, 1:55 PM ET: Latest 722.68 · Change +0.20% today · What is driving it Technology exposure ahead of Fed and earnings catalysts. [1][23][38]
• 7–10-YEAR TREASURY, IEF ETF, 1:55 PM ET: Latest 90.91 · Change −0.21% today · What is driving it Upward yield pressure ahead of the Fed decision. [1][34]
• 20+-YEAR TREASURY, TLT ETF, 1:55 PM ET: Latest 81.46 · Change −0.21% today · What is driving it Long-duration valuation sensitivity. [1]
• 10-YEAR TREASURY PAR YIELD: Latest 4.99%, October 27 close · Change / · What is driving it Discount-rate benchmark for future earnings. [2]
6. WHAT INVESTORS SHOULD WATCH NEXT
• WEDNESDAY, OCTOBER 28, 2:00 PM ET—FEDERAL RESERVE DECISION: CNBC reported roughly 92% odds of holding the 3.75%–4.00% target range; guidance about further tightening could matter more to software valuations than the expected hold. [38]
• WEDNESDAY, 2:30 PM ET—FED PRESS CONFERENCE: The policy outlook will help determine whether the October 27 4.99% 10-year Treasury close becomes a more demanding valuation reference point. [2][27]
• WEDNESDAY AFTER THE CLOSE—ALPHABET AND MICROSOFT EARNINGS: Alphabet’s expected 25% revenue growth and an options-implied 5.8% stock move make the release a significant test of AI sentiment; enterprise-demand and spending commentary from both companies will help frame the software opportunity. [10][23]
• THROUGH THE REST OF THE WEEK—ANALYST ATTRIBUTION: For any expanded software roster, match each ticker to the underlying note’s date, author, thesis and explicit rating language; the October 27 open-weight argument and the October 8 Goldman upgrade answer different questions. [3][4]
• MONDAY, NOVEMBER 2—PALANTIR EARNINGS: Watch whether management’s demand and delivery commentary supports Goldman’s sovereign-AI and automation argument underlying its $230 target. [4][7]
• MONGODB’S NEXT OPERATING UPDATE: Track AI-native growth alongside the 3%–5% revenue share, the 40% AI-use-case ARR measure and the mid-20% Atlas growth objective; sustained breadth would be more persuasive than the 165% cohort growth rate alone. [5]
7. ANALYST TAKEAWAY
THE OPPORTUNITY IS SHARED; THE EVIDENCE AND VALUATION JUDGMENTS ARE COMPANY-SPECIFIC. Morgan Stanley’s October 27 open-weight thesis connects MDB and PLTR through enterprise context and pricing power. MongoDB’s September operating measures and Goldman’s October Palantir upgrade then supply distinct routes to monetization. Combining those routes into one analyst basket obscures rather than strengthens the case. [3][4][5]
The bull scenario is that cheaper intelligence increases software usage while enterprise integration preserves pricing power. Signposts would include MongoDB sustaining broad Atlas adoption and delivering against its above-20% total-revenue growth objective, alongside Palantir demonstrating that deployment automation can scale sovereign and vertical-AI demand. [3][4][5]
The bear scenario is that adoption grows faster than monetization: MongoDB’s small AI-native revenue base limits consolidated impact, Palantir’s delivery requirements constrain scalability, and elevated yields compress the value assigned to future growth. Those are risks to test against operating results—not outcomes established by an analyst list. [2][4][5]
The biggest analytical risk is confusing a thematic mention with a dated recommendation. The biggest opportunity investors are weighing is whether enterprise software captures durable economic value as models become cheaper. The next earnings releases can sharpen that distinction; a longer ticker list cannot. [3][7][23]
Prepared for informational and educational purposes only. Not financial advice.
SOURCES
© Copyright 2024. All Rights Reserved.
© Copyright 2024. All Rights Reserved.